GGrantIndex
Sort

27,075 grants matching cholesterol

Colorado Nurse Family Heart Trial for the ENRICH program

$945,434
Mandy Atlee Allison · University Of Colorado Denver · UH3 · FY2024 · HL

Oral PCSK9/LDLR antagonist direction to the clinic

$945,393
Nabil A Elshourbagy · Shifa Biomedical Corporation · R44 · FY2021 · HL

Functions of KSHV microRNAs and circular RNAs

$944,767
Joseph Ziegelbauer · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Exploring the Mechanism of HMG-CoA Reductase With Time-Resolved Laue Diffraction

$944,728
Cynthia V Stauffacher · Purdue University · · FY2005 · BIO

Leptin as a Therapy for Alzheimer's Disease

$944,180
Nikolaos Tezapsidis · Neurotez, Inc. · R44 · FY2010 · AG

Oral PCSK9/LDLR antagonist direction to the clinic

$943,895
Nabil A Elshourbagy · Shifa Biomedical Corporation · R44 · FY2020 · HL

A nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention (EXTRA-CVD)

$942,293
Chris Todd Longenecker · Case Western Reserve University · U01 · FY2020 · HL

The Molecular Genetics of Hemostasis

$941,106
David Ginsburg · University Of Michigan At Ann Arbor · R35 · FY2024 · HL

The Molecular Genetics of Hemostasis

$941,106
David Ginsburg · University Of Michigan At Ann Arbor · R35 · FY2025 · HL

Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression

$940,683
M. Celeste Simon · University Of Pennsylvania · R35 · FY2022 · CA

High throughput infrastructure for reaction screening and bioassays

$940,354
Robert Graham Cooks · Purdue University · UG3 · FY2023 · TR

Targeted Analysis Resource - Wadsworth Center's Children's Health Exposure Assessment Resource (WC CHEAR)

$939,487
Patrick Jeremy Parsons · Wadsworth Center · U2C · FY2015 · ES

Towards a More Accurate Model of the Plasma Membrane: Influence of Cholesterol on Phase Behavior and Nonrandom mixing of Membrane Components

$939,066
Gerald W Feigenson · Cornell University · · FY2014 · BIO

Dietary Modification Of Brain Aging And Neurodegenerative Disorders

$938,026
Mark P Mattson · Aging · Z01 · FY2007 · AG

Influence of Cholesterol on Phase Behavior and Nonrandom Mixing of Membrane Components

$937,104
Gerald W Feigenson · Cornell University · · FY2009 · BIO

HORMONAL REGULATION OF MAMMALIAN GENE EXPRESSION

$935,934
Ronald M. Evans · Salk Institute For Biological Studies · R37 · FY2009 · DK

Animal Models of Diabetic Vascular Disease

$934,670
Rockefeller University · U01 · FY2005 · HL

Comprehensive CVD Risk Reduction Trial in Persons with Serious Mental Illness

$934,036
Gail L Daumit · Johns Hopkins University · R01 · FY2017 · HL

Indianapolis-Ibadan Dementia Project

$933,797
Kathleen S Hall · Indiana University Indianapolis · R01 · FY2010 · AG

Nervous System Development and Plasticity

$932,104
Richard Douglas Fields · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD

Endocannabinoids And Appetitive Functions

$931,718
George Kunos · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA

Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause

$931,497
Susan S. Girdler · Univ Of North Carolina Chapel Hill · R01 · FY2012 · MH

Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression

$931,087
M. Celeste Simon · University Of Pennsylvania · R35 · FY2019 · CA

Institutional Career Development Core

$931,073
Barry Coller · Rockefeller University · KL2 · FY2019 · TR

Genome-Wide Study of Cataract and Low HDL in the Personalized Medicine Research P

$930,265
Catherine Anne McCarty · Marshfield Clinic Research Foundation · U01 · FY2009 · HG